Aids Weekly Plus
Xinhua Net reported that the United States had funded and launched a research project that aimed to assess the cost-effectiveness of HIV/AIDS activities in Cambodia in relation to their impact and to help the Cambodian government build an evidence base for planning and decision-making. Men Chean Rithy, HIV Innovate and Evaluate Project coordinator, stated the United States would give $6.3 million to the University Research Company throughout 4.5 years to complete the project. Rithy noted that the project would focus on Cambodians with the highest HIV risk.
Rebecca Black, director of the US Agency for International Development to Cambodia, affirmed that the project would work closely with Cambodia’s government and other development partners to support the Cambodian national HIV/AIDS efforts. In addition to generating data for policy and program enhancements, the project would document challenges and achievements.
The National AIDS Authority of Cambodia estimated HIV prevalence among Cambodian adults ages 15–49 years was 0.7 percent in 2013, in comparison with 0.8 percent in 2011, and 2.5 percent in 1998. The agency estimated 71,347 HIV-infected people lived in Cambodia at present; of this number, 38,420 were females and 6,850 were children. Approximately 85 percent of HIV-infected Cambodians have received antiretroviral drugs. In 2012, Cambodia estimated HIV mortality at 2,365 and incidence at 1,330. HIV incidence in the early 1990s was approximately 15,500 per year.
Health Minister Mam Bunheng asserted that Cambodia intended to reach the UN “Three Zeros” goals—zero new HIV infections, zero stigma and discrimination, and zero AIDS-related deaths—by 2020. Cambodia was one of the few countries that had reversed the spread of HIV and was on track to eliminate HIV transmission by 2020.